Schroder Investment Management Group Neurocrine Biosciences Inc Transaction History

Schroder Investment Management Group

$94.5 Billion
Q3 2024

A detailed history of Schroder Investment Management Group transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Schroder Investment Management Group holds 211,274 shares of NBIX stock, worth $26.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

211,274

Previous 185,384 13.97%

Holding current value

$26.5 Million

Previous $25.5 Million 4.69%

% of portfolio

0.03%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$114.58 - $153.15 $2.97 Million - $3.97 Million	25,890 Added 13.97%	211,274 $24.3 Million
Q2 2024 Aug 12, 2024	BUY	$130.86 - $143.19 $4.61 Million - $5.05 Million	35,257 Added 23.48%	185,384 $25.5 Million
Q1 2024 May 14, 2024	BUY	$130.4 - $143.74 $9.73 Million - $10.7 Million	74,592 Added 98.75%	150,127 $20.7 Million
Q4 2023 Feb 13, 2024	BUY	$106.07 - $132.76 $1.9 Million - $2.38 Million	17,931 Added 31.13%	75,535 $9.95 Million
Q3 2023 Nov 14, 2023	SELL	$94.02 - $117.1 $534,879 - $666,181	-5,689 Reduced 8.99%	57,604 $6.48 Million
Q2 2023 Aug 11, 2023	BUY	$89.53 - $104.87 $667,088 - $781,386	7,451 Added 13.34%	63,293 $5.97 Million
Q1 2023 May 11, 2023	BUY	$94.11 - $123.02 $4.59 Million - $5.99 Million	48,729 Added 685.07%	55,842 $5.65 Million
Q4 2022 Feb 10, 2023	SELL	$106.72 - $127.06 $354,203 - $421,712	-3,319 Reduced 31.82%	7,113 $849,000
Q3 2022 Nov 10, 2022	BUY	$92.03 - $107.81 $960,056 - $1.12 Million	10,432 New	10,432 $1.11 Million
Q4 2019 Feb 11, 2020	SELL	$86.8 - $118.57 $276,024 - $377,052	-3,180 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$83.82 - $101.5 $23,301 - $28,217	278 Added 9.58%	3,180 $287,000
Q2 2019 Aug 08, 2019	SELL	$72.24 - $91.27 $814,433 - $1.03 Million	-11,274 Reduced 79.53%	2,902 $245,000
Q1 2019 May 14, 2019	BUY	$69.31 - $91.53 $377,046 - $497,923	5,440 Added 62.27%	14,176 $1.25 Million
Q4 2018 Feb 14, 2019	SELL	$68.32 - $124.36 $697,820 - $1.27 Million	-10,214 Reduced 53.9%	8,736 $624,000
Q3 2018 Nov 13, 2018	SELL	$98.88 - $125.85 $548,685 - $698,341	-5,549 Reduced 22.65%	18,950 $2.33 Million
Q1 2018 May 11, 2018	SELL	$75.88 - $92.43 $339,714 - $413,809	-4,477 Reduced 15.45%	24,499 $2.03 Million
Q4 2017 Feb 09, 2018	SELL	$58.53 - $77.59 $475,790 - $630,729	-8,129 Reduced 21.91%	28,976 $2.25 Million
Q3 2017 Nov 09, 2017	BUY	$47.97 - $61.28 $1.78 Million - $2.27 Million	37,105	37,105 $2.2 Million

Others Institutions Holding NBIX

# of Institutions

629

Shares Held

94.2M

Call Options Held

692K

Put Options Held

406K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account

Schroder Investment Management Group Neurocrine Biosciences Inc Transaction History